Fluoroethyl-L-tyrosine (18F)
Clinical data | |
---|---|
Other names | 18F-FET; O-(2-(18F)fluoroethyl)-l-tyrosine, O-(2-Fluorethyl)-l-thyrosine, l-(18F)FET[1] |
Routes of administration | Intravenous |
ATC code | |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
Chemical and physical data | |
Formula | C11H14FNO3 |
Molar mass | 227.235 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
|
Fluoroethyl-l-tyrosine (18F) or 18F-FET is a neuro-oncologic PET tracer.[2]
See also
- Fluoroethyl
References
- ↑ CID 54255856 from PubChem
- ↑ Galldiks N, Stoffels G, Filss C, Rapp M, Blau T, Tscherpel C, et al. (September 2015). "The use of dynamic O-(2-18F-fluoroethyl)-l-tyrosine PET in the diagnosis of patients with progressive and recurrent glioma". Neuro-Oncology. 17 (9): 1293–300. doi:10.1093/neuonc/nov088. PMC 4588758. PMID 26008606.
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.